Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
Century Therapeutics (NASDAQ:IPSC) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Century Therapeutics (NASDAQ:IPSC) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $2.00 price target on the stock, down previously from $7.00.
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update